跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PREGABALINA CINFA 225 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PREGABALINA CINFA 225 MG CAPSULAS DURAS EFG
Approved
STANDARD
PREGABALINA CINFA 225 MG CAPSULAS DURAS EFG
Laboratorios Cinfa S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 28, 2020
Approval ID
3ac269c42fe50bfd
Company
Laboratorios Cinfa S.A.
Type
Standard
Approval Details
Approval Id
3ac269c42fe50bfd
Drug Cima Aemps Name
PREGABALINA CINFA 225 MG CAPSULAS DURAS EFG
Register Number
85278
Holder Company Name
Laboratorios Cinfa S.A.
Marketing Company Name
Laboratorios Cinfa S.A.
Authorization Date
2020-07-28
Dosage Form
CÁPSULA DURA
Dose
225 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Laboratorios Cinfa S.A.
Active Ingredients
PREGABALINA
225 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 28, 2020
Approval ID
3ac269c42fe50bfd
Type
Standard
Back to CIMA-AEMPS Approvals
